Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome
Condition(s):Type 2 Diabetes Mellitus; Chronic Kidney Disease; Left Ventricular Diastolic DysfunctionLast Updated:May 17, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Type 2 Diabetes Mellitus; Chronic Kidney Disease; Left Ventricular Diastolic DysfunctionLast Updated:May 17, 2023Completed
Condition(s):Cardiac RehabilitationLast Updated:March 26, 2019Unknown status
Condition(s):Diastolic Heart FailureLast Updated:May 18, 2015Completed
Condition(s):Microvascular Coronary Dysfunction; Cardiovascular DiseaseLast Updated:July 20, 2023Recruiting
Condition(s):HypertensionLast Updated:December 3, 2019Unknown status
Condition(s):Angina, Unstable; Myocardial Infarction; Ischemic Heart DiseaseLast Updated:October 5, 2018Completed
Condition(s):Diastolic Dysfunction; Septic ShockLast Updated:March 6, 2018Unknown status
Condition(s):Hypertrophic CardiomyopathyLast Updated:May 9, 2022Completed
Condition(s):Young Healthy Adults; Ventricular DysfunctionLast Updated:July 1, 2010Terminated
Condition(s):Hypertrophic CardiomyopathyLast Updated:November 28, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.